Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

EXPRESS SCRIPTS HOLDING CO (ESRX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Express Scripts Earnings Surged 74%; Forecast Clears Lowered Hurdle

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/18/2013 | 11:18pm CET
   By Jon Kamp 
 

Pharmacy-benefit manager Express Scripts Holding Co. (>> Express Scripts Holding Co) reported a 74% surge in fourth-quarter earnings, helped by a major acquisition, while forecasting 2013 earnings mostly ahead of a Wall Street target the company helped drag lower three months ago.

The St. Louis-based company--which manages drug-benefit programs for health plans and corporate customers--rattled analysts in November when it said their forecasts for 2013 looked too high. Express Scripts didn't release its own guidance at the time, but said a still-weak economy was weighing on the number of prescriptions it handles.

Monday's release finally included company guidance for adjusted earnings of $4.20 to $4.30 per share this year. The target is largely above the $4.20 forecast among analysts surveyed by Thomson Reuters, although Express Scripts' November warning caused analysts to trim the consensus forecast by about 30 cents since then.

This will mark the first full year of combined operations for Express Scripts and Medco Health Solutions, which created the largest pharmacy-benefit manager, or PBM, following April's $29.1 billion Medco acquisition.

"2012 was a monumental year for Express Scripts as we closed the acquisition of Medco and made significant progress integrating the two companies," George Paz, Express Scripts' chief executive, said in a press release.

The company plans to hold a conference call Tuesday morning. Its shares are up about 2.9% so far this year, through Friday's close, trailing a 6.6% gain in the Standard & Poor's 500 index.

The company reported fourth-quarter earnings of $504.1 million, or 61 cents a share, up from $290.4 million, or 59 cents a share, a year earlier. Excluding deal-related costs and other items, per-share earnings rose to $1.05 from 82 cents.

Revenue more than doubled to $27.41 billion from the year-earlier period, which was before the Medco deal.

Analysts surveyed by Thomson Reuters had forecast earnings of $1.04 a share on sales of $27.24 billion. Analysts are forecasting lower sales in coming quarters as health insurer UnitedHealth Group Inc. (>> UnitedHealth Group Inc.) brings in-house the PBM business it had outsourced to Medco.

Express Scripts saw adjusted claims--a measure that takes into account monthly prescriptions filled in retail pharmacies and 90-day fills through the company's mail-order business--rise 111% in the recent quarter to 410.8 million.

The company's full-year adjusted claims tally about matched its target by nearing 1.4 billion. The company expects 5% to 7% growth in adjusted claims this year.

Its adjusted earnings forecast represents 12% to 15% growth.

Write to Jon Kamp at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Express Scripts Holding Co, UnitedHealth Group Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EXPRESS SCRIPTS HOLDING CO
02/13EXPRESS SCRIPTS : Group of Missouri lobbyists leave Dentons, form Nexus Group
AQ
02/07EXPRESS SCRIPTS : reports lower growth rate in drug spend
AQ
02/07EXPRESS SCRIPTS : reports lower growth rate in drug spending
AQ
02/06EXPRESS SCRIPTS : Reduces Employers' Annual Prescription Drug Spending Growth Ra..
PU
01/31Amazon, Berkshire, JPM healthcare deal rocks incumbents
AQ
01/31Express Scripts and Centene shares fall on Amazon's bid to tackle health care..
AQ
01/31Health investors roll out unwelcome mat for Amazon's arrival
RE
01/31Amazon, Berkshire, JPMorgan partner to cut U.S. healthcare costs
RE
01/31Amazon, Berkshire, JPMorgan partner to cut U.S. healthcare costs
RE
01/31Amazon, Berkshire, JPMorgan partner to cut U.S. healthcare costs
RE
More news
News from SeekingAlpha
02/14Tracking Seth Klarman's Baupost Group Holdings - Q4 2017 Update 
02/13EXPRESS SCRIPTS : Worth At Least $80 
02/11DRUG PRICING : The Endgame Has Started 
02/07INVESTMENT IDEAS : Beating The Market By Focusing On Cash Distributions 
02/07YOUR DAILY PHARMA SCOOP : Nabriva Pullback, GW Pharmaceuticals Makes Progress, C.. 
Financials ($)
Sales 2017 99 873 M
EBIT 2017 7 058 M
Net income 2017 3 446 M
Debt 2017 13 876 M
Yield 2017 -
P/E ratio 2017 12,94
P/E ratio 2018 10,28
EV / Sales 2017 0,56x
EV / Sales 2018 0,52x
Capitalization 41 951 M
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Technical analysis trends EXPRESS SCRIPTS HOLDING CO
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Average target price 82,3 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Neal Sample Chief Operating Officer & Executive Vice President
James M. Havel Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDING CO-0.76%42 438
CVS HEALTH-3.74%70 697
WALGREENS BOOTS ALLIANCE-5.69%67 851
MCKESSON CORPORATION-4.60%31 015
CARDINAL HEALTH9.91%21 192
AMERISOURCEBERGEN4.99%21 176